These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20935166)

  • 21. The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands.
    Anisimov A; Leppänen VM; Tvorogov D; Zarkada G; Jeltsch M; Holopainen T; Kaijalainen S; Alitalo K
    Sci Signal; 2013 Jul; 6(282):ra52. PubMed ID: 23821770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
    Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
    FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of soluble forms of vascular endothelial growth factor receptors, sVEGFR-1 and sVEGFR-2, in bovine dominant follicles.
    Macias VR; Pinzón C; Fierro F; Vergara M; Martínez D; Rosado A; Gutiérrez CG; Rosales-Torres AM
    Reprod Domest Anim; 2012 Jun; 47(3):e39-42. PubMed ID: 21988522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiogenesis in fetal tendon development: spatial and temporal expression of the angiogenic peptide vascular endothelial cell growth factor.
    Petersen W; Pufe T; Kurz B; Mentlein R; Tillmann B
    Anat Embryol (Berl); 2002 Jul; 205(4):263-70. PubMed ID: 12136256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model.
    Ji K; Minakawa M; Fukui K; Suzuki Y; Fukuda I
    Ann Thorac Cardiovasc Surg; 2008 Aug; 14(4):210-7. PubMed ID: 18818569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance.
    Wada H; Satoh N; Kitaoka S; Ono K; Morimoto T; Kawamura T; Nakano T; Fujita M; Kita T; Shimatsu A; Hasegawa K
    Atherosclerosis; 2010 Feb; 208(2):512-7. PubMed ID: 19695569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.
    Hornig C; Barleon B; Ahmad S; Vuorela P; Ahmed A; Weich HA
    Lab Invest; 2000 Apr; 80(4):443-54. PubMed ID: 10780661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of VEGF and its receptors in different brain tumors.
    Huang H; Held-Feindt J; Buhl R; Mehdorn HM; Mentlein R
    Neurol Res; 2005 Jun; 27(4):371-7. PubMed ID: 15949234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor and its soluble receptors-1 and -2 in iris neovascularization and neovascular glaucoma.
    Noma H; Mimura T; Yasuda K; Shimura M
    Ophthalmologica; 2014; 232(2):102-9. PubMed ID: 24942011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGFR-2-mediated increased proliferation and survival in response to oxygen and glucose deprivation in PlGF knockout astrocytes.
    Freitas-Andrade M; Carmeliet P; Stanimirovic DB; Moreno M
    J Neurochem; 2008 Nov; 107(3):756-67. PubMed ID: 18786179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2.
    Zhao B; Cai J; Boulton M
    Microvasc Res; 2004 Nov; 68(3):239-46. PubMed ID: 15501243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells.
    Garvin S; Nilsson UW; Dabrosin C
    Br J Cancer; 2005 Oct; 93(9):1005-10. PubMed ID: 16234819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.
    Tsatsaris V; Goffin F; Munaut C; Brichant JF; Pignon MR; Noel A; Schaaps JP; Cabrol D; Frankenne F; Foidart JM
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5555-63. PubMed ID: 14602804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
    Ohno-Matsui K; Yoshida T; Uetama T; Mochizuki M; Morita I
    Biochem Biophys Res Commun; 2003 Apr; 303(3):962-7. PubMed ID: 12670505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor and its soluble receptor in benign and malignant ovarian tumors.
    Artini PG; Ruggiero M; Monteleone P; Carpi A; Cristello F; Cela V; Genazzani AR
    Biomed Pharmacother; 2008; 62(6):373-7. PubMed ID: 18037256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.
    Sands M; Howell K; Costello CM; McLoughlin P
    Respir Res; 2011 Jan; 12(1):17. PubMed ID: 21266048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.
    Shyu KG; Liou JY; Wang BW; Fang WJ; Chang H
    J Biomed Sci; 2005; 12(2):409-20. PubMed ID: 15942707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of vascular endothelial growth factor bioactivity in patients with acute lung injury.
    Perkins GD; Roberts J; McAuley DF; Armstrong L; Millar A; Gao F; Thickett DR
    Thorax; 2005 Feb; 60(2):153-8. PubMed ID: 15681505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.
    Malik AK; Baldwin ME; Peale F; Fuh G; Liang WC; Lowman H; Meng G; Ferrara N; Gerber HP
    Blood; 2006 Jan; 107(2):550-7. PubMed ID: 16189273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
    Romero R; Nien JK; Espinoza J; Todem D; Fu W; Chung H; Kusanovic JP; Gotsch F; Erez O; Mazaki-Tovi S; Gomez R; Edwin S; Chaiworapongsa T; Levine RJ; Karumanchi SA
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):9-23. PubMed ID: 18175241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.